| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | Director | Director, 10% Owner
3 companies
Meeker David P is a Director at TRVI, with reported holdings spanning 3 companies. Recent filings cover 3 purchases and 12 sales. Those positions are worth an estimated $2.0M at current prices.
Our model assigns Meeker David P a below-average insider score of 31/100, based on 7 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -57.9%.
Meeker David P's largest disclosed position is in RYTM as President and CEO, worth about $1.4M. The recent filings there lean toward selling, a net 122,649 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | RYTM Rhythm Pharmaceuticals, Inc. | President and CEO | Sale+OE10b5-1 | 50,000 | $102.67 | $5,133,442.06 | -17.3% | - | - | |
| Jun 3, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | President and CEO | Sale+OE10b5-1 | 43,620 | $65.05 | $2,837,333.35 | -17.8% | +58.7% | +33.8% | |
| Feb 19, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | President and CEO | Sale+OE10b5-1 | 9,896 | $57.22 | $566,249.12 | -4.7% | +10.1% | +77.9% | |
| Feb 4, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | President and CEO | Sale+OE | 4,278 | $59.43 | $254,241.54 | -2.2% | +7.4% | +80.1% | |
| Aug 27, 2024 | TRVI Trevi Therapeutics, Inc. | Director | Sale+OE | 4,555 | $2.93 | $13,352.53 | -1.3% | +0.3% | +174.9% | |
| Mar 19, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | President and CEO | Sell | 45,494 | $39.22 | $1,784,274.68 | -20.7% | +5.2% | +41.1% | |
| Feb 1, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | President and CEO | Sale+OE | 4,361 | $45.06 | $196,506.66 | -3.5% | -10.6% | +28.3% | |
| Mar 30, 2021 | RYTM Rhythm Pharmaceuticals, Inc. | President and CEO | Buy | 10,000 | $20.17 | $201,713.00 | +9.9% | +1.5% | -44.2% | |
| May 9, 2019 | TRVI Trevi Therapeutics, Inc. | Director, 10% Owner | Buy | 11,250 | $10.00 | $112,500.00 | +3.3% | - | - | |
| Oct 10, 2017 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Buy | 25,000 | $17.00 | $425,000.00 | +32.8% | - | - |